SCHEMBL13007347

SCHEMBL13007347

C=CC1CCC(NC)C(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9499149 0.77 ALDH1A1 (0.31)
SCHEMBL23519932 0.72 L3MBTL1 (0.31)
SCHEMBL14048601 0.72 L3MBTL1 (0.31)
SCHEMBL12166914 0.71 CA1 (0.37)
SCHEMBL19494958 0.71
SCHEMBL19019044 0.70
SCHEMBL14197692 0.70
SCHEMBL31483455 0.70 KDM1A (0.32)
SCHEMBL7972779 0.69
SCHEMBL7972784 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3553133-A1 POLYMER COMPOSITIONS AND METHODS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2019-10-16 EP disclosed
EP-1487802-B1 2,3-Diaryl-pyrazolidine derivatives as neurotensin degrading enzyme inhibitors ABBOTT HEALTHCARE PRODUCTS BV (NL) 2010-12-29 EP disclosed